These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 30617701)

  • 1. [Glucose metabolism in older patients].
    Laurentius T; Freitag M; Eitner J; Eisert A; Bertsch T; Bollheimer LC
    Internist (Berl); 2019 Feb; 60(2):133-140. PubMed ID: 30617701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of aging and insulin resistant states on protein anabolic responses in older adults.
    Morais JA; Jacob KW; Chevalier S
    Exp Gerontol; 2018 Jul; 108():262-268. PubMed ID: 29723655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The antidiabetic action of camel milk in experimental type 2 diabetes mellitus: an overview on the changes in incretin hormones, insulin resistance, and inflammatory cytokines.
    Korish AA
    Horm Metab Res; 2014 Jun; 46(6):404-11. PubMed ID: 24627103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulinotropic and muscle protein synthetic effects of branched-chain amino acids: potential therapy for type 2 diabetes and sarcopenia.
    Manders RJ; Little JP; Forbes SC; Candow DG
    Nutrients; 2012 Nov; 4(11):1664-78. PubMed ID: 23201839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of the antidiabetic drugs on the age-related atrophy and sarcopenia associated with diabetes type II.
    Cetrone M; Mele A; Tricarico D
    Curr Diabetes Rev; 2014; 10(4):231-7. PubMed ID: 25245021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Type II diabetes mellitus.
    Edelman SV
    Adv Intern Med; 1998; 43():449-500. PubMed ID: 9506190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Differential therapy with oral antidiabetic drugs].
    Sachse G
    Z Gesamte Inn Med; 1993 Mar; 48(3):127-9. PubMed ID: 8475635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel SIRT1 activator E6155 improves insulin sensitivity in type 2 diabetic KKA
    Liu P; Feng T; Zuo X; Wang X; Luo J; Li N; Han X; Zhu N; Xu S; Xu Y; Jin ZG; Si S
    Biochem Biophys Res Commun; 2018 Apr; 498(3):633-639. PubMed ID: 29524414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Effects of Blood Glucose Regulation in Omentin-1 Levels among Diabetic Patients.
    Arman Y; Kirna K; Ugurlukisi B; Kutlu O; Dikker O; Cil EO; Akarsu M; Ozcan M; Yuruyen G; Demir P; Altun O; Ozsenel EB; Erdem MG; Sandikci R; Tukek T
    Exp Clin Endocrinol Diabetes; 2017 Apr; 125(4):262-266. PubMed ID: 28073124
    [No Abstract]   [Full Text] [Related]  

  • 10. Diabetes and branched-chain amino acids: What is the link?
    Bloomgarden Z
    J Diabetes; 2018 May; 10(5):350-352. PubMed ID: 29369529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short-term intensive insulin therapy in type 2 diabetes mellitus: a systematic review and meta-analysis.
    Kramer CK; Zinman B; Retnakaran R
    Lancet Diabetes Endocrinol; 2013 Sep; 1(1):28-34. PubMed ID: 24622264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin resistance and sarcopenia: mechanistic links between common co-morbidities.
    Cleasby ME; Jamieson PM; Atherton PJ
    J Endocrinol; 2016 May; 229(2):R67-81. PubMed ID: 26931135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Insulin secretion and aging. Implications for insulin therapy in the geriatric patient with diabetes mellitus].
    Fritsche A; Stumvoll M; Häring HU
    Med Klin (Munich); 2003 Apr; 98(5):287-91. PubMed ID: 12721675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The current aspects of the pharmacological correction of hyperglycemia in patients with non-insulin-dependent diabetes mellitus (type 2)].
    Gorbenko NI
    Eksp Klin Farmakol; 1999; 62(5):71-8. PubMed ID: 10572759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Combination therapy of oral antidiabetic drugs with insulin].
    Lotz N; Bachmann W
    Z Gesamte Inn Med; 1993 Mar; 48(3):130-4. PubMed ID: 8475636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug therapy of diabetes in the elderly.
    Oiknine R; Mooradian AD
    Biomed Pharmacother; 2003; 57(5-6):231-9. PubMed ID: 12888259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathophysiology of type 1 and type 2 diabetes mellitus: a 90-year perspective.
    Zaccardi F; Webb DR; Yates T; Davies MJ
    Postgrad Med J; 2016 Feb; 92(1084):63-9. PubMed ID: 26621825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved glycemic control enhances the incretin effect in patients with type 2 diabetes.
    An Z; Prigeon RL; D'Alessio DA
    J Clin Endocrinol Metab; 2013 Dec; 98(12):4702-8. PubMed ID: 24092826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New approaches to treating type 2 diabetes mellitus in the elderly: role of incretin therapies.
    Abbatecola AM; Maggi S; Paolisso G
    Drugs Aging; 2008; 25(11):913-25. PubMed ID: 18947259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Insulin analogs and new antidiabetic agents. Prospects in diabetes therapy].
    Gallwitz B; Schmidt WE
    Internist (Berl); 1997 Jun; 38(6):617-24; discussion 624. PubMed ID: 9265011
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.